We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Gene Identified for Usher Syndrome

By LabMedica International staff writers
Posted on 16 Oct 2012
A novel type of gene has been identified and found to be associated with Usher syndrome, a hereditary disease in which affected individuals lose both hearing and vision. More...


Several genes associated with different types of Usher syndrome have been identified and most of these genes encode common structural and motor proteins that build sensory cells in the eye and inner ear.

A team of researchers from multiple institutions, led by those from the University of Cincinnati (OH, USA) studied 14 affected individuals from families with nonsyndromic deafness and two affected individuals from a family with Usher Syndrome. Peripheral blood samples or buccal swabs for genomic DNA extraction were collected from participating subjects.

The team identified a gene on chromosome 15 and determined that its mutations are responsible for nonsyndromic deafness and Usher syndrome type (USH1J). A calcium and integrin binding protein 2 (CIB2) was found to be interacting with other proteins associated with Usher syndrome. They established that CIB2 is localized at the tips of mechanosensory stereocilia of the inner ear hair cells, exactly where the conversion of sound waves into electrical signals occurs. They found that in Pakistan, CIB2 mutations are one of the prevalent genetic causes of nonsyndromic hearing loss. In the USA, approximately six in every 100,000 babies born have Usher syndrome.

The scientists concluded that CIB2 mutations underlie USH1J and nonsyndromic deafness. They speculated that because the Cib2 gene is concentrated in stereocilia and interacts with myosin VIIa and whirlin. The Cib2 morphants have reduced hair cell microphonic potential, and that CIB2 participates in calcium regulation in the mechanotransduction process. Their studies reveal that, in humans, Cib2 is critical for proper photoreceptor maintenance and function and that CIB2 has conserved roles in calcium homeostasis. The study was published on September 30, 2012, in the journal Nature Genetics.

Related Links:

University of Cincinnati



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.